Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07717-3Source: DataRank Database

Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study is a research paper published in Breast Cancer Research and Treatment (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (40)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Samantha M. Thomas ORCID,Ian Halliday ORCID,Astrid Botty van den Bruele,Akiko Chiba ORCID,Kendra J. Modell Parrish

Live enrichment

PubMed:40349259

NIH

Grant: P30CA014236

NIH

Grant: K12AR084231

National Institutes of Health

Grant: 5P30CA014236-30

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

National Institutes of Health

Grant: 3K12AR084231-24S1

Building Interdisciplinary Research Careers in Women's Health (K12) - Administrative Supplement

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12118946/pdf/nihms-2083804.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-025-07717-3.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-025-07717-3/fulltext.html

https://doi.org/10.1007/s10549-025-07717-3

https://pubmed.ncbi.nlm.nih.gov/40349259

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansBreast NeoplasmsReceptors, EstrogenAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingTreatment OutcomeChemotherapy, AdjuvantNeoadjuvant TherapyRetrospective StudiesDatabases, FactualAdultAgedMiddle AgedFemalePathologic Complete ResponseErb-b2 Receptor Tyrosine Kinases

Keywords

Breast cancerChemotherapyEndocrine TherapyNeoadjuvant TherapyPathologic Complete ResponseEstrogen Positive Breast CancerAdultDatabases, FactualAntineoplastic Agents, HormonalBreast NeoplasmsMiddle AgedErb-b2 Receptor Tyrosine KinasesTreatment OutcomeReceptors, EstrogenChemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesAgedNeoplasm Staging